Latest Articles

Publication Date
Protein Loss Predicts EC Prognosis - Physician's Weekly

Protein Loss Predicts EC Prognosis Physician's Weekly

Published: Dec. 5, 2024, 3:24 p.m.
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - Canada NewsWire

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer Canada NewsWire

Published: Dec. 5, 2024, 2:43 p.m.
Supreme Court seems ready to uphold ban on gender-affirming care for minors - Texas Standard

Supreme Court seems ready to uphold ban on gender-affirming care for minors Texas Standard

Published: Dec. 5, 2024, 2:42 p.m.
Supreme Court seems ready to uphold ban on gender-affirming care for minors - KDLG

Supreme Court seems ready to uphold ban on gender-affirming care for minors KDLG

Published: Dec. 4, 2024, 6:25 p.m.
Supreme Court hears challenge to law banning gender-affirming care for trans kids - KCBX

Supreme Court hears challenge to law banning gender-affirming care for trans kids KCBX

Published: Dec. 4, 2024, 10 a.m.
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update comes in li - Defense World

Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update …

Published: Dec. 4, 2024, 8:10 a.m.
Amy Schumer Addresses Comments on Her 'Puffier' Face and Provides Health Update - AOL

Amy Schumer Addresses Comments on Her 'Puffier' Face and Provides Health Update AOL

Published: Dec. 4, 2024, 6:49 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News - StockTitan

Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News StockTitan

Published: Dec. 4, 2024, 12:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News - StockTitan

Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News StockTitan

Published: Dec. 4, 2024, midnight
Free Press report: former egg donors share hidden risks of giving away genetics - CatholicVote org

Free Press report: former egg donors share hidden risks of giving away genetics CatholicVote org

Published: Dec. 3, 2024, 9:51 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!